Abstract:Abnormal glycan structures are valuable biomarkers for disease states; the development of glycan-specific binders is thereby significantly important. However, the structural homology and weak immunogenicity of glycans pose major hurdles in the evolution of antibodies, while the poor availability of complex glycans also has extremely hindered the selection of anti-glycan aptamers. Herein, we present a new approach to efficiently screen aptamers toward specific glycans with a complex structure, using a glycosylated peptide as a scaffold. In this method, using peptide-imprinted magnetic nanoparticles (MNPs) as a versatile platform, a glycopeptide tryptically digested from a native glycoprotein was selectively entrapped for positive selection, while a nonglycosylated analogue with an identical peptide sequence was synthesized for negative selection. Alternating positive and negative selection steps were carried out to guide the directed evolution of glycan-binding aptamers. As proof of the principle, the biantennary digalactosylated disialylated <i>N</i>-glycan A2G2S2, against which there have been no antibodies and lectins so far, was employed as the target. With the glycoprotein transferrin as a source of target glycan, two satisfied anti-A2G2S2 aptamers were selected within seven rounds. Since A2G2S2 is upregulated in cancerous liver cells, carboxyfluorescein (FAM)-labeled aptamers were prepared as fluorescent imaging reagents, and successful differentiation of cancerous liver cells over normal liver cells was achieved, which demonstrated the application feasibility of the selected aptamers. This approach obviated a tedious glycan preparation process and allowed favorable expose of the intrinsic flexible conformation of natural glycans. Therefore, it holds great promise for developing glycan-specific aptamers for challenging applications such as cancer targeting.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.0c03675?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.0c03675</a>.Experimental details; MALDI-TOF MS spectra; characterization of BA-MNPs; structures of the silylating monomers; FI-IR spectra; the selectivity of peptide-imprinted MNPs; predicted secondary structures of the aptamers; binding affinity measurement of the candidate aptamers; the specificity test; modified and unmodified ssDNA sequences; SELEX screening conditions; and sequences of aptamer candidates (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.0c03675/suppl_file/ac0c03675_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

[Screening and Structure Analysis of the Aptamers Against Human Recombinant S100A8 Protein].

Screening and characterization of aptamers for recombinant human programmed death-1 and recombinant extracellular domain of human programmed death ligand-1

Functionalized Aptamer with an Antiparallel G-quadruplex: Structural Remodeling, Recognition Mechanism, and Diagnostic Applications Targeting CTGF.

In Silico Design and Validation of High-Affinity RNA Aptamers Targeting Epithelial Cellular Adhesion Molecule Dimers

Selection and Identification of a DNA Aptamer That Mimics Saxitoxin in Antibody Binding

FAM Tag Size Separation-Based Capture-Systematic Evolution of Ligands by Exponential Enrichment for Sterigmatocystin-Binding Aptamers with High Specificity

Efficient Screening of Glycan-Specific Aptamers Using a Glycosylated Peptide as a Scaffold

In Vitro Selection and Characterization of Deoxyribonucleic Acid Aptamers Against Connective Tissue Growth Factor.

Development of Apatmer Screening Against Proteins and Its Applications

Selection and characterization of an ssDNA aptamer against thyroglobulin

Selection and Characterization of a DNA Aptamer Recognizing High Mobility Group Box 1 Protein (HMGB1) and Enhancing Its Pro-inflammatory Activity

Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications

Screening of Aptamer for Human IgG Fc Fragment by Capillary Electrophoresis-Systematic Evolution of Ligands by Exponential Enrichment

Identifying high-affinity aptamer ligands with defined cross-reactivity using high-throughput guided systematic evolution of ligands by exponential enrichment

Screening Ssdna Aptamers Against HIV P24 Antigen Using Agarose Beads As Carriers

Investigation of the Relationship between Aptamers' Targeting Functions and Human Plasma Proteins

Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment.

Aptamers from Cell-based Selection for Bioanalysis and Bioimaging

Combining Use of a Panel of Ssdna Aptamers in the Detection of Staphylococcus Aureus

Aptamers Against Cell Surface Receptors: Selection, Modification and Application

[Selection and Identification of Ssdna Aptamers Specific to Clinical Isolates of Streptococcus Mutans Strains with Different Cariogenicity].